$ISIS Up to date company activities and other impo
Post# of 44955
Posted On: 03/07/2014 10:30:26 AM
$ISIS Up to date company activities and other important information about $ISIS
$ISIS
DD Notes ~ http://www.ddnotesmaker.com/ISIS
##### recent news/filings ~ source: finance.yahoo.com
Thu, 06 Mar 2014 23:07:34 GMT ~ Nasdaq stocks posting largest percentage increases
- A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: InterCloud Systems rose 22.9 percent to $12.90. Bind Therapeutics rose 12.0 percent to $15.40. RiceBran Tech rose 10.6 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stock...nance.html
*********************************************************
Thu, 06 Mar 2014 14:39:51 GMT ~ Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
- CARLSBAD, Calif., March 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Barclays ...
read full: http://www.noodls.com/view/E271A050008217C258...FA17CBCAF3
*********************************************************
Thu, 06 Mar 2014 12:00:00 GMT ~ Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
- CARLSBAD, Calif., March 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Barclays Global Healthcare Conference on Thursday, March 13, 2014 at 9:00 a.m. ET in Miami, FL. A live webcast of the presentation will be available on the "Investors & Media" section of the Company's website, www.isispharm.com. A replay will be available on the Isis website within 48 hours and will be archived for a limited time. Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis' broad pipeline consists of 31 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, including neurological disorders, and cancer. Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO®, in the United States and other countries for the treatment of patients with homozygous FH. Isis' patents provide strong and extensive protection for its drugs and technology. Isis' patents provide strong and extensive protection for its drugs and technology. Additional information about Isis is available at www.isispharm.com.
read full: http://finance.yahoo.com/news/isis-pharmaceut...00534.html
*********************************************************
Wed, 05 Mar 2014 19:32:08 GMT ~ Why Isis Pharmaceuticals Continues to Impress
read full: http://www.fool.com/investing/general/2014/03...lnk0000001
*********************************************************
Wed, 05 Mar 2014 16:50:00 GMT ~ Arrowhead Research: 'Early Innings' for 'Major Story'
read full: http://blogs.barrons.com/stockstowatchtoday/2...p;ru=yahoo
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=ISIS&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=ISIS&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ISIS/company-info
Ticker: $ISIS
OTC Market Place: Not Available
CIK code: 0000874015
Company name: Isis Pharmaceuticals, Inc.
Company website: http://www.isip.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/ISIS/filings
Latest financials: http://www.otcmarkets.com/stock/ISIS/financials
Latest news: http://www.otcmarkets.com/stock/ISIS/news - http://finance.yahoo.com/q/h?s=ISIS+Headlines
Major holdings: http://data.cnbc.com/quotes/ISIS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ISIS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ISIS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ISIS
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Isis+Pharmaceutica...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.isip.com
Alexa: http://www.alexa.com/siteinfo/http://www.isip.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.isip.com
Short Sales: http://www.otcmarkets.com/stock/ISIS/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ISIS/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ISIS/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ISIS+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ISIS+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ISIS+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ISIS+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ISIS+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ISIS+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ISIS
Balance Sheet: http://finance.yahoo.com/q/bs?s=ISIS
Cash Flow: http://finance.yahoo.com/q/cf?s=ISIS+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ISIS
Bloomberg: http://www.bloomberg.com/quote/ISIS:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ISIS
Bussinessweek: http://investing.businessweek.com/research/st...icker=ISIS
Barchart: http://www.barchart.com/quotes/stocks/ISIS
OTC Short Report: http://otcshortreport.com/index.php?index=ISIS
Investopedia: http://www.investopedia.com/markets/stocks/ISIS/?wa=0
http://www.pennystocktweets.com/stocks/profile/ISIS
##### last known share structure ~ source: otcmarkets.com
Market Value: $6,497,943,167 a/o Mar 06, 2014
Shares Outstanding: 117,270,225 a/o Feb 21, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/ISIS
$ISIS
DD Notes ~ http://www.ddnotesmaker.com/ISIS
##### recent news/filings ~ source: finance.yahoo.com
Thu, 06 Mar 2014 23:07:34 GMT ~ Nasdaq stocks posting largest percentage increases
- A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: InterCloud Systems rose 22.9 percent to $12.90. Bind Therapeutics rose 12.0 percent to $15.40. RiceBran Tech rose 10.6 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stock...nance.html
*********************************************************
Thu, 06 Mar 2014 14:39:51 GMT ~ Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
- CARLSBAD, Calif., March 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Barclays ...
read full: http://www.noodls.com/view/E271A050008217C258...FA17CBCAF3
*********************************************************
Thu, 06 Mar 2014 12:00:00 GMT ~ Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
- CARLSBAD, Calif., March 6, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Barclays Global Healthcare Conference on Thursday, March 13, 2014 at 9:00 a.m. ET in Miami, FL. A live webcast of the presentation will be available on the "Investors & Media" section of the Company's website, www.isispharm.com. A replay will be available on the Isis website within 48 hours and will be archived for a limited time. Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis' broad pipeline consists of 31 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, including neurological disorders, and cancer. Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO®, in the United States and other countries for the treatment of patients with homozygous FH. Isis' patents provide strong and extensive protection for its drugs and technology. Isis' patents provide strong and extensive protection for its drugs and technology. Additional information about Isis is available at www.isispharm.com.
read full: http://finance.yahoo.com/news/isis-pharmaceut...00534.html
*********************************************************
Wed, 05 Mar 2014 19:32:08 GMT ~ Why Isis Pharmaceuticals Continues to Impress
read full: http://www.fool.com/investing/general/2014/03...lnk0000001
*********************************************************
Wed, 05 Mar 2014 16:50:00 GMT ~ Arrowhead Research: 'Early Innings' for 'Major Story'
read full: http://blogs.barrons.com/stockstowatchtoday/2...p;ru=yahoo
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=ISIS&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=ISIS&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ISIS/company-info
Ticker: $ISIS
OTC Market Place: Not Available
CIK code: 0000874015
Company name: Isis Pharmaceuticals, Inc.
Company website: http://www.isip.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/ISIS/filings
Latest financials: http://www.otcmarkets.com/stock/ISIS/financials
Latest news: http://www.otcmarkets.com/stock/ISIS/news - http://finance.yahoo.com/q/h?s=ISIS+Headlines
Major holdings: http://data.cnbc.com/quotes/ISIS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ISIS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ISIS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ISIS
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Isis+Pharmaceutica...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.isip.com
Alexa: http://www.alexa.com/siteinfo/http://www.isip.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.isip.com
Short Sales: http://www.otcmarkets.com/stock/ISIS/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ISIS/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ISIS/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ISIS+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ISIS+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ISIS+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ISIS+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ISIS+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ISIS+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ISIS
Balance Sheet: http://finance.yahoo.com/q/bs?s=ISIS
Cash Flow: http://finance.yahoo.com/q/cf?s=ISIS+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ISIS
Bloomberg: http://www.bloomberg.com/quote/ISIS:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ISIS
Bussinessweek: http://investing.businessweek.com/research/st...icker=ISIS
Barchart: http://www.barchart.com/quotes/stocks/ISIS
OTC Short Report: http://otcshortreport.com/index.php?index=ISIS
Investopedia: http://www.investopedia.com/markets/stocks/ISIS/?wa=0
http://www.pennystocktweets.com/stocks/profile/ISIS
##### last known share structure ~ source: otcmarkets.com
Market Value: $6,497,943,167 a/o Mar 06, 2014
Shares Outstanding: 117,270,225 a/o Feb 21, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/ISIS
(0)
(0)